The Latest: Harvard heads to court in $2.6B lawsuit against Trump administration
If U.S. District Judge Allison Burroughs decides in the university's favor, the ruling would reverse a series of funding freezes that later became outright cuts as the administration escalated its fight with the nation's oldest and wealthiest university. Such a ruling, if it stands, would revive Harvard's sprawling scientific and medical research operation and hundreds of projects.
Harvard's lawsuit accuses the administration of waging a retaliation campaign against the university after it rejected a series of demands in an April 11 letter from a federal antisemitism task force.
Here's the latest:
However, even with the nation's largest endowment at $53 billion, the university has warned it can't absorb the full cost of the federal cuts.
Federal agencies say grants can be scrapped if they no longer align with government policies
In court filings, Harvard has said the government 'fails to explain how the termination of funding for research to treat cancer, support veterans, and improve national security addresses antisemitism.'
The Trump administration denies the cuts were made in retaliation, saying the grants were under review even before the April demand letter was sent. It argues the government has wide discretion to cancel contracts for policy reasons.
Hearing begins in Harvard's lawsuit over funding cuts
A lawyer for Harvard opened the hearing by saying the Trump administration violated the university's First Amendment rights by cutting more than $2.6 billion in federal funding.
Steven Lehotsky said the government conditioned research grants on Harvard, 'ceding control' to the government over what is appropriate for students and faculty to say.
US envoy doubles down on support for Syria's government and criticizes Israel's intervention
A U.S. envoy doubled down on Washington's support for Syria's new government, saying Monday there is 'no Plan B' to working with it to unite the country still reeling from years of civil war and wracked by new sectarian violence.
In an exclusive interview with The Associated Press, Tom Barrack also criticized Israel's recent intervention in Syria, calling it poorly timed and saying it complicated efforts to stabilize the region.
Barrack is ambassador to Turkey and special envoy to Syria, with a short-term mandate in Lebanon. He spoke in Beirut following more than a week of clashes in Syria's southern province of Sweida between militias of the Druze religious minority and Sunni Muslim Bedouin tribes.
Tom Barrack, who is ambassador to Turkey and special envoy to Syria and also has a short-term mandate in Lebanon, told The Associated Press that Israel's intervention in the latest round of conflict in Syria had further complicated matters. (AP Video shot by Fadi Tawil; Production by Abby Sewell)
Syrian government forces intervened, ostensibly to restore order, but ended up siding with the Bedouins before withdrawing under a ceasefire agreement with Druze factions. Hundreds have been killed in the fighting, and some government fighters allegedly shot dead Druze civilians and burned and looted homes.
Neighboring Israel intervened last week on behalf of the Druze, who are seen as a loyal minority within Israel and often serve in its military. Israel launched dozens of strikes on convoys of government forces in Sweida and struck the Ministry of Defense headquarters in central Damascus.
Over the weekend, Barrack announced a ceasefire between Syria and Israel. Syrian government forces have redeployed in Sweida to halt renewed clashes between the Druze and Bedouins, and civilians from both sides were set to be evacuated Monday.
▶ Read more about the U.S. support for Syria's new government
Trump threatens to hold up stadium deal if Washington Commanders don't switch back to Redskins
Trump is threatening to hold up a new stadium deal for Washington's NFL team if it does not restore its old name of the Redskins, which was considered offensive to Native Americans.
Trump also said Sunday that he wants Cleveland's baseball team to revert to its former name, the Indians, saying there was a 'big clamoring for this' as well.
The Washington Commanders and Cleveland Guardians have had their current names since the 2022 seasons, and both have said they have no plans to change them back. Trump said the Washington football team would be 'much more valuable' if it restored its old name. His latest interest in changing the name reflects his broader effort to roll back changes that followed a national debate on cultural sensitivity and racial justice.
The Commanders and the District of Columbia government announced a deal earlier this year to build a new home for the football team at the site of the old RFK Stadium, the place the franchise called home for more than three decades.
▶ Read more about Trump's attempt to strongarm the NFL team
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
29 minutes ago
- The Independent
White House uses Jet2 meme to promote ICE deportations
The White House has posted a controversial tweet on X using a viral British airline advert meme to seemingly mock migrants being deported. The tweet featured handcuffed undocumented individuals being escorted onto an ICE-contracted flight, captioned with a sarcastic reference to a " Jet2 holiday to deportation." The post sparked widespread outrage among social media users, who condemned it as "disgusting" and "mind blowing." Singer Jess Glynne, whose song is part of the meme, expressed her disgust, stating her music promotes "love, unity, and spreading positivity," not "division or hate." The incident aligns with President Donald Trump 's recent signing of a law allocating significant funds for border enforcement and his pledge to deport millions of undocumented immigrants.
The Guardian
30 minutes ago
- The Guardian
FDA's top vaccine official leaves post after less than four months
The top vaccine official at the US Food and Drug Administration (FDA), Vinay Prasad, has left the federal agency less than four months after being appointed as the head of the division overseeing biological products like blood, vaccines, and cellular and gene therapies, a government spokesperson has said. Prasad, an oncologist and a professor of epidemiology, biostatistics and medicine at the University of California, San Francisco, had previously criticized the FDA. He was a fierce critic of US Covid-19 vaccine and mask mandates and, in the second Trump administration, he was controversially appointed as the director of the FDA's center for biologics evaluation and research in May. 'Dr Prasad did not want to be a distraction to the great work of the FDA in the Trump administration and has decided to return to California and spend more time with his family,' a spokesperson from the Department of Health and Human Services told Reuters in an emailed statement on Tuesday evening. Endpoints News first reported Prasad's departure. The government gave no details about the reason for his departure but he had fierce critics on both sides of the political aisle and the Washington Post reported, citing unnamed sources, that he had been ousted amid protests by conservative voices, with no response from Prasad to requests for comment. His exit came after a number of unusual regulatory actions, including those taken recently by the agency on Sarepta Therapeutics' gene therapy, Elevidys. 'Unprecedentedly, there were multiple press leaks from the FDA, negatively impacting [the drug's] credibility,' said Kostas Bilouris, BMO Capital Markets analyst. During Prasad's short stint in post, the FDA limited the use of Covid-19 vaccines and declined to approve therapies from biotech companies Replimune, which sought the green light for a treatment for advanced melanomas, and Capricor Therapeutics' treatment for a form of muscular dystrophy. The regulator's decisions under Prasad raised concerns that he was anti-patient choice, Jefferies analyst Roger Song said, adding that investors will see his departure as a positive for gene therapy and vaccine makers. Biotech stocks had plunged at the news of Prasad's appointment in May. The Nasdaq Biotechnology Index had declined 7% then, but later recovered. Shares of Replimmune rose 58%, Sarepta was up 11.2% and Capricor added 21.2% in premarket trading on Wednesday. Prasad also held the additional role of the agency's chief medical and science officer, to which he was appointed last month, according to STAT News. Nominating a more seasoned official to replace him could help the FDA rebuild its credibility, Bilouris said.
The Guardian
30 minutes ago
- The Guardian
DoJ pushes for release of Epstein and Maxwell grand jury transcripts
Transcripts of the grand jury proceedings that led to the sex trafficking indictments of the sex abuser Jeffrey Epstein and his accomplice, British socialiate Ghislaine Maxwell, include the testimony of just two law enforcement witnesses, the Department of Justice has said, as it argues for the documents' release. Top justice department officials disclosed in a filing late on Tuesday in New York City federal court that separate grand juries convened to consider the criminal investigations of Epstein and Maxwell, and had heard from only two witnesses. The revelation was made in the course of court wrangling over whether the transcripts of the proceedings should be unsealed, amid the continuing furor over the Epstein scandal which has roiled Donald Trump's second term. The Trump administration is urging the two federal judges who presided over the Epstein and Maxwell grand juries, Richard Berman and Paul Engelmayer, to release the testimony, in an attempt to calm the uproar. The Trump administration has come under intense pressure from the president's own base of supporters who were infuriated by the justice department's decision not to release any additional Epstein files about the late, disgraced financier's crimes involving the sex trafficking of girls. The decision jarred with the previous stance of senior administration figures, including Trump himself and the US attorney general, Pam Bondi, who had hyped the expected release of more details of the New York financier's businesses, travels and associations, including a possible list of his financial clients, which all further stoked conspiracies around the well-connected Epstein. Tuesday's submission states that the grand jury tasked with considering the criminal case against Epstein heard only from an FBI agent when it met in June and July 2019. A similar grand jury for Maxwell heard from the same FBI agent and a New York police department detective when it met in June and July 2020 and in March 2021. The memorandum was signed by Jay Clayton, US attorney for the southern district of New York, and included the names of Bondi and deputy attorney general Todd Blanche. Epstein took his own life in a federal jail in August 2019, weeks after his arrest on federal sex trafficking charges, officials say, but his case has generated endless attention and conspiracy theories because of his and Maxwell's links to famous people, such as royals, presidents and billionaires, including Trump. Maxwell is serving a 20-year prison sentence for conspiring with Epstein in the sexual trafficking of minors. She was convicted in December 2021 on charges that she lured teenage girls to be sexually abused by Epstein. Last week, she sat for two sets of interviews with justice department officials, including Blanche, in Florida, where she is serving her time in a federal prison, and answered questions 'about 100 different people', her attorney said. Trump has denied prior knowledge of Epstein's crimes and claimed he had cut off their relationship long ago. But he faces ongoing questions about the Epstein case.. On Tuesday, Trump spoke about connections between Epstein and the president's Mar-a-Lago club in Florida. He claimed he evicted the financier from the resort because Epstein 'stole' young female staffers from him, including Virginia Giuffre who went on to be a key witness against Epstein and Maxwell. Giuffre died in April. Maxwell has offered to testify before Congress but with conditions, including being granted immunity. Her lawyer has written to the House committee which has subpoenaed her saying that a deposition without immunity would be a 'non-starter'. The justice department memorandum says unsealing the transcripts is 'consistent with increasing calls for additional disclosures in this matter'. The Associated Press contributed reporting
